NASDAQ: ALZN
Linkedin Facebook-f Twitter Instagram
Alzamend
  • About us
    • Corporate Overview
    • Management Team
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Scientific Advisory Board
  • Science
    • Product Pipeline
    • Publications
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Presentations
    • Financial Results
    • Stock Data
    • SEC Filings
    • Governance
  • Contact
    • Contact Us
    • Careers
Menu
  • About us
    • Corporate Overview
    • Management Team
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Scientific Advisory Board
  • Science
    • Product Pipeline
    • Publications
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Presentations
    • Financial Results
    • Stock Data
    • SEC Filings
    • Governance
  • Contact
    • Contact Us
    • Careers

In The News

Investors

Investors

  • Overview
  • News & Events
    • Press Releases
    • In The News
    • IR Calendar
    • Email Alerts
  • Company Info
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Presentations
  • Financial Results
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News & Events

  • Press Releases
  • In The News
  • IR Calendar
  • Email Alerts
Dec 28, 2022

Alzamend Neuro Partners With Stem Cell Institute For Immunotherapy Vaccine Trial For Dementia

Nov 16, 2022

CEO Stephan Jackman interviewed on Fox Business News

Aug 12, 2022

Alzamend Neuro aiming to rapidly develop and market safe and effective treatments for Alzheimer's

Aug 4, 2022

Alzamend Neuro Stock Pops After Benzinga Exclusive On Cognition Therapeutics Alzheimer's Data

Jul 21, 2022

FDA provides guidance to Alzamend ahead of IND application for oral therapeutic

rss_feed RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
Alzamend

Making Alzheimer’s
Just a Memory™

About

  • Overview
  • Management
  • Board of Directors

Investor Relations

  • Overview
  • News & Events
  • Company Info
  • Presentations
  • Financial Results
  • Stock Data
  • SEC Filings
  • Governance

Other

  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Safe Harbor

© 2016-23 Alzamend Neuro, Inc. All rights reserved.

Twitter Facebook-f Instagram Linkedin